FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

APELLIS PHARMACEUTICALS, INC.: net_income

One fact, its scope and the complete path back to the official record.

Period: 2025-01-01 – 2025-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/c10d0516-c934-4a1f-a6a2-4a6e81f86ed8

Reported value

$22.388M{"amount": 22388000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Entity
APELLIS PHARMACEUTICALS, INC.
Metric
net_income
Period
2025-01-01 – 2025-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001193125-26-065179 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T14:51:44.561314+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001492422/net-income/2025-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.